ClinicalTrials.gov
ClinicalTrials.gov Menu

Effects Of Rosiglitazone (Extended Release Tablets) On Cerebral Glucose Utilisation And Cognition Alzheimers Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00334568
Recruitment Status : Terminated (Slow recruitment)
First Posted : June 8, 2006
Last Update Posted : January 14, 2013
Sponsor:
Information provided by (Responsible Party):
GlaxoSmithKline

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : July 2007
  Actual Study Completion Date : July 2007